Closing Bell: Medicenna Therapeutics Corp down on Wednesday (MDNA)

Today, shares of Medicenna Therapeutics Corp opened at $2.18 and closed at $2.11. It traded at a low of $2.08 to a high of $2.23.

Share prices dipped -2.31 percent from the previous day's close of $2.16.

Today across North America, the TSX Composite closed -0.45% at 21880.95, the S&P 500 closed -0.77% at 5199.50, the Dow Jones Industrial Average closed -0.60% at 38763.45 and the Nasdaq Composite closed 1.03% at 16366.85.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

A total of 82,245 shares was traded during the session, with total trades of 200, while having an average volume of 116,632 over 5 days.

The TSX overall saw 1,858 price advancers against 3,319 declines and 108 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, in the last 12 months, Medicenna Therapeutics Corp's shares have risen 276.79 percent, while this year, they have risen 402.38%.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $165.09 million on a float of 76,433 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Medicenna Therapeutics Corp's consensus rating is "Strong Buy" based on 2 analysts according to Zacks. Currently, there are 2 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..